Stevanato Group Announces Change in Ex-Dividend Date for its Dividend
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has changed the previously announced ex-dividend date of June 5, 2023 for its cash dividend of EUR 0.054 per share, payable on July 17, 2023, to comply with New York Stock Exchange rules. The new ex-dividend date for the dividend will be June 7, 2023, and the record date remains June 6, 2023. The dividend will continue to be payable on July 17, 2023.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group's core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
The flow diversion aneurysm treatment market size is expected to grow by USD 2.11 billion from 2022 to 2027. In addition, the momentum of the market will be progressing at a CAGR of 8.8% during the forecast period, according to Technavio Research....
The dietary supplements market size is expected to grow by USD 61.4 billion from 2022 to 2027, according to Technavio. In addition, the growth momentum of the market will progress at a CAGR of 8.16% during the forecast period. Increasing adoption of...
In the news release, Public-sector contract talks - Tens of thousands demonstrate in Montréal to defend public services, issued 23-Sep-2023 by Alliance du personnel professionnel et technique de la santé et des services sociaux (APTS) over PR...
More than 7,500 participants took a giant step forward for youth mental health today, crossing the finish line for the 11th anniversary of RBC Race for the Kids in Toronto. Collectively they raised $2.5 million in support of Family Navigation Project...
On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the YL201 Phase I/II Investigators Meeting hosted by Suzhou MediLink Therapeutics Co., Ltd. The...
